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Background & aims: Obesity is characterized by fat mass excess (FM), extra cellular water increase (ECW)
and, with ageing, decrease in fat free mass (FFM). The validity of body impedance analysis (BIA) in pa-
tients with mild to severe obesity is still debated. The purpose of this study is to describe the Resistance
(Rz) and Reactance (Xc) values obtained by Body Impedance Analysis (BIA) in a wide cohort of Italian
patients with mild to severe obesity. The secondary endpoint is to describe the resulting body compo-
sition values (as percentage and indexes) in this population.
Methods: The study enrolled adult in-patients with mild to severe obesity (classified with class I, II and III
obesity) undergoing clinical care rehabilitation program for obesity complications and weight loss. BIA
values were grouped by sex, BMI and age classes.
Results: A total of 8303 patients with obesity, aged 18 to 90 y, were studied. The Resistance (Rz) and
Reactance (Xc) were reported by sex, age and BMI classes. In women and men both, the phase angle
(PhA) decreases with increasing BMI (kg/m2) and the resulting BIA vector was significantly shifted. The
FM index (FMI) was higher (p < 0.0001) in women while FFM index (FFMI) was higher in men
(p < 0.0001) and significantly associated with BMI. FFMI decreased with age in both sex (p < 0.0001).
Skeletal mass (SM) presents a progressive reduction in relation to age and gender both.
Conclusions: The present BIA-based body composition analysis in a wide cohort of mild to severe obese
patients revealed a significantly decreased Rz and Xc values with a consequent significant decrease of
PhA in a BMI-dependent manner. The body compartments estimation with available equations was BMI,
sex and age dependent. These observational results could be the basis for the development of new
equations adapted for patients suffering from obesity.
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The analysis of body composition is a fundamental part of
nutritional status assessment especially in weight loss programs.
Body weight and its composition are the result of genetics, meta-
bolism, environment, behavior, and culture; furthermore, it is
demonstrated that local fat accumulation has significant, adverse
impact for morbidity (i.g. Cardiovascular diseases and diabetes),
disability (i.g. overload of articular with functional reduction),
emotional well-being and quality of life (i.g. work discrimination
and reduction of social life). In patients with obesity the relative
abundance and the functional relationships of fat mass (FM) and
fat-free mass (FFM) result in important change of human energy
control [1]. Evaluation of body compartments is important when
considering that weight regain after weight loss frequently results
in an increased amount of fat mass (FM) that can be greater than
the FM initially lost [2]. The FFM is heterogeneous and includes
skeletal muscle mass (SMM), organ mass, bone, body fluids and
connective tissue associated with adipose tissue. The appendicular
SMM is essential because its loss during weight loss can compro-
mise physical function.
Bioelectrical impedance analysis (BIA) is a simple, noninvasive,
rapid, portable, reproducible, and convenient method of measuring
body composition and fluid distribution with fewer physical de-
mands. The BIA is based upon the principle that the impedance of a
geometrical system is related to conductor length and configura-
tion, its cross-sectional area and the signal frequency. Using a
constant signal frequency and a relatively constant conductor
configuration, bioelectrical impedance to the flow of a current can
be related to the volume of the conductor. Different BIA analyzers
are available in the commerce. The analyzers can be classified
basing on the used electrical current frequency into multi-
frequency (MF-BIA) and single-frequency (SF-BIA) analyzers. MF-
BIA uses different frequencies (0, 1, 5, 50, 100, 200, 500 kHz) to
evaluate different body compartments. For the estimation of body
composition, the frequency frequencies 50 kHz have been used.
However, the most routinely used for the estimation is an alter-
nating sinusoidal electric current of 400 lA at a single operating
frequency of 50 kHz (SF-BIA) [3]. However, BIA does not measure
body composition directly. It measures two bioelectrical parame-
ters: body resistance (Rz) and reactance (Xc) and from these derives
the Phase Angle (PhA). The PhA has been interpreted as an indicator
of membrane integrity and water distribution between the intra-
and extracellular spaces [4] and an indirect estimate of body cell
mass [5e7]. It also been used as a nutritional status indicator in
adults and children [8,9]. Considering that BIA-derived body com-
partments rely on a constant level of hydration, all subjects with
fluid overload might be at risk for overestimation of FFM.
In patients with obesity, BIA has specific limitations mainly
due to the assumptions of constant hydration and body fluids
distribution to obtain a valid estimate of FFM [10]. Other factors,
including body size and shape (cross-sectional areas in trunk and
limbs) that depend on weight, body fat distribution, as well as
age, gender and ethnicity, which are independent predictors of
body composition, impact BIA-estimates of FFM. The designation
of appropriate cut-offs ranges for FM, FFM and SMM in patients
with BMI >35 kg/m2 are not clearly defined, and routinely values
established on normal weight subjects are used. The validity of BIA
in obese and morbidly obese patients is then still debated [3,11,12].
The gold standard techniques for measuring body composition
and total body water are isotope dilution (labelled deuterium), dual
energy X-ray absorptiometry (DXA), underwater weighing and air-
displacement plethysmography. Abdominal and visceral fat can
be measured with computed tomography (CT) and magnetic
resonance imaging (MRI). These techniques, however, require3974special facilities and cannot be used for daily bedside measure-
ments. Hence since BMI cannot be a reliable predictor of FM on the
single obese patient, and the cost/effectiveness of DXA, we tested
the hypothesis of body composition analysis by BIA testing a wide
cohort of patients with mild to severe obesity and of different age
decades. For this aim, the main goal of this study was then to
describe, in a large cohort of Caucasian (Italian) patients with mild
to severe obesity, the body composition BIA parameters, the
derived FM, FFM and SMM percentage and indexes by sex, age and
BMI classes.
2. Materials and methods
2.1. Subjects
We enrolled patients from two specialized centers for obesity
care and metabolic rehabilitation [Endocrinology and Nutrition
Unit of IRCCS - Istituto Auxologico Italiano (San Giuseppe Hospital,
Piancavallo, VB, Italy (recruitment center 1) and the Endocrinology
and Nutrition Unit, Azienda di Servizi alla Persona, University of
Pavia, Pavia, Italy (recruitment center 2)]. The inclusion criteria
were (BMI) 30 kg/m2 and age 18 yr. The exclusion criteria were:
obese patients suffering from liver, heart, lung or kidney failure or
peripheral vein thrombosis, patients with abnormal body geometry
(such as arm or leg amputation) and patients with clinical condition
suggesting peripheral fluid overload (¼ considered as body hy-
dration 80%) (Fig. 1) [13]. The study was carried out in accordance
with The Code of Ethics of the World Medical Association and
performed under the approval of the Ethics Committee of IRCCS
Istituto Auxologico Italiano (approval code #2017_05_16_09 and
amendment code #2018_04_17_14). Participants gave their written
consent prior to participation in this study.
2.2. Weight and height assessment
Body weight (kg) and body height (m) were measured to the
nearest 0.1 kg and 0.5 cm respectively, using a mechanical column
scale (Scale-Tronix, Wheaton, IL) and a stadiometer (Scale-Tronix,
Wheaton, IL), and BMI was calculated as body weight/height
squared (kg/m2). The two recruitment centers were provided with
the same equipment.
2.3. Body composition measurements
The BIA measurements were performed in the early morning,
after a 12-h overnight fast, using a phase-sensitive, single-fre-
quency bioimpedance analyzer (BIA 101, Akern, Pisa, Italy), which
applies an alternating-current of 400 mA at 50 kHz. The instru-
mentation used in the two recruitment centres was the same (i.e.
BIA 101, Akern, Pisa, Italy), checked by the manufacturer, and with
the same procedure of calibration and controls. Before each testing
session, the external calibration of the instrument was checked
with a calibration circuit of known impedance value (Rz¼ 470 Ohm
and Xc ¼ 90 Ohm, 1% error). The mean coefficient of variation was
1% for within-day and 3% for intra-individual measurements in the
steady state condition and 2% for the inter-operator variability in
both centres. Before the measurement, each subject removed
clothing and metal jewellery and rested in a supine position for
5 min, to equilibrate body fluids. The impedance measurements
were made with subjects with a leg opening of approximately 45
compared to the median line of the body and the upper limbs
positioned about 30 away from the trunk [14]. After cleaning the
skin with alcohol, two Ag/AgCl low-impedance electrodes (Biatr-
odes, Akern Srl, Florence, Italy) were placed on the back of the
right hand and two electrodes on the corresponding foot, with a
Fig. 1. Flow chart of enrolled/excluded patients with brief indication of selection criteria.
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calculated as (R2þXc2)0.5 and PhA as the arctangent of [Xc/R x 180/
p]. We normalized the raw data of impedance measurements of Rz
and Xc by the height (H, m) of an individual patient [e.g., Rz/H and
Xc/H in U/m] to illustrate individual and group values on the RzXc
graph. Patients with water or electrolyte imbalances (i.e. edema or
ascites) were identified with vectors outside of the 70% tolerance
ellipses (hyperhydrated subjects) using the Rz/Xc graph (BIVA
software) by Piccoli et al. [15]. The FFM (kg) was calculated by using
the population-based prediction model of Sun S. et al. [16]. The
value of FFM divided by H2 (squared meters) was the FFM index
(FFMI¼ FFM/H2) [17]. The FMwas calculated by difference between
body weight and FFM. The value of FM divided by squared meter
height was the fat mass index (FMI ¼ FM Kg/H2) [17]. Total SMM
(kg) was calculated using the prediction equation of Janssen et al.
[18]. As for FFMI, also the SMM was normalized by body surface as
index following the equation (SMI) ¼ SMM (kg)/H2 (m). The
equations used are validated for Caucasian population ranging from
18 to 86 yr with BMI 16e48 kg/m2 [19,20]. The sex and age specific
percentiles for SMI (kg/m2) were calculated considering the whole
sample. The cut-off values for SMI, previously reported by a Jansen I
et al. [19] were used to define SM amount (kg) and to check
whether there was a decreased in muscle mass as needed param-
eter for the diagnosis of sarcopenia (i.e. SMI <8.5 kg/m2 for men and
<5.75 kg/m2 for women with body weight in a normal range).
2.4. Statistical analysis
The continuous data are reported as mean ± standard deviation
(SD) and 95% confidence interval (CI 95%) assuming a normal dis-
tribution of data (tested by means of ShapiroeWilk). Gender-
specific tolerance ellipse at 50%, 75% and 95% are built by plotting
R/H and Xc/H and compared to tolerance ellipse built by Piccoli
et al. [21]. Tolerance ellipse is a region that contains a given pro-
portion of the population. ANOVA models are implemented to
investigate the effect of three covariates sex, age, BMI (categorical
variables) and their interactions on each of the following variables:
Phase Angle (PhA), FFM, FFMI, FM, FMI, total body water (TBW),
extracellular water (ECW) and SMI [16]. To perform post hoc
comparisons among the different BMI categories considered versus
the reference class (BMI 30e35 kg/m2) the Dunnett's adjustment
was applied to control the inflation of type I error. To describe3975the distribution of selected anthropometric variables in obese
population we reported the 10th, 25th, 50th, 75th and 90th per-
centiles. A p < 0.05 was considered statistically significant. All
statistical analyses were performed using Statistical Analysis Sys-
tem Software (SASS version 9.2; SAS Institute, Cary, NC) while
tolerance ellipses were drawn using the Bodygram Plus™ software
(Akern™).
3. Results
We obtained a total of 11,163 BIA assessments (8405 assess-
ments from patients with diagnosis of obesity at center 1 and
2758 at recruitment center 2). Peripheral fluid overload was
observed in 9.4% of the whole patients cohort. Patients that did not
met the inclusion criteria were excluded, then resulting in a total of
8303measures from patients with BMI [mean (SD)] 42.60 (7.19) Kg/
m2; age 57 (16) yr of which men were 3659 (44%) with BMI 41.68
(6.95) Kg/m2 and age 57 (16) yr, and womenwere 4644 (56%) with
BMI 43.32 (6.95) Kg/m2 and age 56 (16) yr in the final dataset. In the
whole group of patients (n ¼ 8303) the mean impedance values
(±SD) were 286.11 ± 54.58 U/m for Rz/H, 22.81 ± 7.51 U/m for Xc/H
and 4.53 ± 1.15 for PhA. In men (N ¼ 3659) the mean Rz/H (±SD)
was 252.08 ± 40.70 U/m and the mean Xc/H (±SD) 20.43 ± 6.50 U/
m for a resulting mean PhA (±SD) of 4.61 ± 1.18, while in women
group (N ¼ 4644), the mean Rz/H (±SD) was 312.92 ± 48.89 U/m,
the mean Xc/H 24.68 ± 7.72 U/m for a mean PhA (±SD) of
4.47 ± 1.12.
Since Rz and Xc depend on sex, BMI and age, we sub-grouped
the measured values by sex, BMI classes (30.0e34.9 kg/m2 for
Obesity class I, 35.0e39.9 kg/m2 Obesity class II, 40e44.9 kg/m2
-45-49.9 kg/m2 and 50 kg/m2 for Obesity Class III) as well as for
age classes (following these decades intervals: 18e29, 30e39,
40e49, 50e59, 60e69 and  70 yr). Table 2 shows the mean values
of Rz and Xc measured and corrected for H and the resulting PhA.
For the same BMI class, an age-dependent decrease in Rz/H and
Xc/H values, together with a progressive decrease in PhA, was
observed in men and women both. Since PhA reflects the ratio be-
tween intra and extracellular water, in obesity it may be affected by
nutritional and hydration status. In healthy subjects, PhA ranges
between 6 and 7 [22] and in athletes itmay reach 8.5 [23] and low
PhA values (such as less than 5) may indicate cellular integrity loss.
The PhA decrease observed in the studied cohort had a significant
Table 1
Bioimpendance values of reactance (Rz), resistance (Xc) corrected on height (H, meters) and phase angle (PhA) of 8303 obese patients (3659 men, panel A and 4644 women,






Age (yr) N Rz/H (U/m) Xc/H (U/m) PhA ()
Mean ± SD 95% CI Mean ± SD 95% CI Mean ± SD 95% CI
30e34.9 All 576 289.98 ± 40.57 [278.66e285.30] 23.39 ± 6.91 [22.83e23.96] 4.73 ± 1.18 [4.63e4.83]
18e29 15 324.07 ± 74.37 [282.88e365.25] 32.24 ± 8.01 [27.81e36.68] 5.74 ± 0.85 [5.27e6.21]
30e39 19 318.32 ± 53.78 [292.4e344.24] 27.97 ± 6.72 [24.73e31.21] 5.02 ± 0.87 [4.6e5.44]
40e49 59 278.78 ± 40.67 [268.18e289.38] 26.47 ± 7.39 [24.54e28.39] 5.4 ± 1.17 [5.1e5.7]
50e59 95 275.11 ± 36.59 [267.66e282.57] 24.06 ± 6.34 [22.77e25.36] 4.99 ± 1.16 [4.76e5.23]
60e69 181 282.65 ± 39.56 [276.85e288.46] 23.63 ± 5.88 [22.76e24.49] 4.79 ± 1.06 [4.64e4.95]
70 207 279.08 ± 35.18 [274.26e283.9] 20.94 ± 6.66 [20.03e21.85] 4.27 ± 1.16 [4.11e4.43]
35e39.9 All 1075 263.12 ± 34.45 [261.05e265.18] 21.62 ± 6.56 [21.22e22.01] 4.68 ± 1.22 [4.61e4.75]
18e29 52 282.92 ± 41.1 [271.48e294.36] 27.01 ± 5.82 [25.39e28.63] 5.47 ± 0.97 [5.2e5.74]
30e39 44 272.37 ± 39.51 [260.36e284.39] 25.37 ± 6.19 [23.49e27.25] 5.35 ± 1.12 [5.01e5.69]
40e49 131 260.99 ± 30.9 [255.65e266.33] 23.44 ± 6.43 [22.33e24.55] 5.11 ± 1.23 [4.9e5.33]
50e59 184 257.09 ± 36.88 [251.73e262.45] 23.25 ± 6.98 [22.24e24.26] 5.14 ± 1.24 [4.96e5.32]
60e69 317 259.02 ± 31.95 [255.49e262.55] 20.93 ± 5.97 [20.27e21.59] 4.59 ± 1.08 [4.47e4.71]
70 347 266.71 ± 33.34 [263.19e270.23] 19.4 ± 5.99 [18.77e20.03] 4.14 ± 1.11 [4.03e4.26]
40e44.9 All 1024 247.73 ± 33.73 [245.66e249.79] 20.15 ± 5.80 [19.79e20.51] 4.64 ± 1.15 [4.55e4.64]
18e29 85 266.36 ± 29.64 [259.97e272.76] 24.06 ± 4.41 [23.11e25.02] 5.18 ± 0.87 [4.99e5.37]
30e39 80 257.5 ± 44.03 [247.7e267.3] 23.66 ± 4.93 [22.56e24.75] 5.3 ± 0.93 [5.09e5.5]
40e49 141 243.59 ± 29.29 [238.72e248.47] 22.09 ± 5.66 [21.15e23.03] 5.2 ± 1.25 [4.99e5.4]
50e59 200 240.42 ± 31.16 [236.08e244.77] 20.19 ± 5.59 [19.41e20.97] 4.77 ± 1.05 [4.63e4.92]
60e69 300 244.55 ± 33.04 [240.79e248.3] 19.24 ± 5.5 [18.61e19.86] 4.48 ± 1.05 [4.36e4.6]
70 218 250.61 ± 33.38 [246.16e255.07] 17.29 ± 5.36 [16.58e18.01] 3.92 ± 1.01 [3.79e4.05]
45e49.9 All 555 235.25 ± 36.31 [232.22e238.27] 18.76 ± 5.65 [18.29e19.23] 4.55 ± 1.13 [4.55e4.64]
18e29 79 262.44 ± 43.87 [252.62e272.27] 23.36 ± 5.06 [22.23e24.5] 5.14 ± 1 [4.91e5.36]
30e39 69 230.6 ± 33.27 [222.61e238.6] 20.26 ± 4.66 [19.14e21.38] 5.03 ± 0.97 [4.8e5.26]
40e49 88 229.2 ± 34.35 [221.92e236.48] 19.95 ± 5.58 [18.77e21.13] 4.97 ± 1.06 [4.74e5.19]
50e59 106 224.95 ± 29.18 [219.33e230.57] 17.99 ± 4.86 [17.05e18.92] 4.55 ± 1.03 [4.36e4.75]
60e69 131 232.4 ± 34.14 [226.5e238.3] 16.63 ± 5.71 [15.65e17.62] 4.06 ± 1.1 [3.87e4.25]
70 82 237.29 ± 32.54 [230.14e244.44] 16.16 ± 4.42 [15.19e17.13] 3.9 ± 0.95 [3.69e4.11]
≥50 All 429 216.51 ± 36.80 [213.02e220.00] 16.38 ± 5.69 [15.84e16.91] 4.29 ± 1.21 [4.18e4.41]
18e29 58 238.67 ± 42.03 [227.62e249.72] 20.22 ± 5.4 [18.8e21.64] 4.86 ± 1.14 [4.56e5.16]
30e39 71 222.78 ± 42.47 [212.72e232.83] 18 ± 5.9 [16.6e19.4] 4.63 ± 1.34 [4.31e4.94]
40e49 117 207.28 ± 29.53 [201.87e212.68] 16.34 ± 5.09 [15.41e17.27] 4.46 ± 1.08 [4.26e4.66]
50e59 79 202.31 ± 32.6 [195e209.61] 14.18 ± 5.39 [12.97e15.38] 3.96 ± 1.19 [3.69e4.23]
60e69 74 220.53 ± 34.47 [212.54e228.51] 15.44 ± 5.53 [14.16e16.72] 3.96 ± 1.08 [3.71e4.21]
70 30 222.37 ± 27.91 [211.95e232.79] 13.33 ± 4.07 [11.81e14.85] 3.43 ± 0.99 [3.06e3.8]
Panel B
Women
BMI (kg/m2) class Age (yr) class N Rz/H (U/m) Xc/H (U/m) PhA ()
Mean ± SD 95% CI Mean ± SD 95% CI Mean ± SD 95% CI
30e34.9 All 498 354.38 ± 50.04 [349.97e358.79] 29.84 ± 7.97 [29.14e30.54] 4.80 ± 1.09 [4.71e4.90]
18e29 49 388.92 ± 62.41 [370.99e406.84] 35.72 ± 8.1 [33.4e38.05] 5.27 ± 1.05 [4.97e5.57]
30e39 44 340.8 ± 40.7 [328.43e353.17] 29.46 ± 7.55 [27.16e31.76] 4.94 ± 1.08 [4.61e5.27]
40e49 47 350.99 ± 42.06 [338.64e363.34] 29.92 ± 7.67 [27.67e32.17] 4.9 ± 1.18 [4.55e5.24]
50e59 96 350.9 ± 39.05 [342.99e358.81] 31.07 ± 7.03 [29.65e32.5] 5.05 ± 0.97 [4.85e5.25]
60e69 98 348.99 ± 51.1 [338.75e359.24] 29.15 ± 8.53 [27.44e30.86] 4.75 ± 1.1 [4.53e4.97]
70 164 353.93 ± 51.7 [345.96e361.9] 27.84 ± 7.43 [26.7e28.98] 4.49 ± 1.04 [4.33e4.65]
35e39.9 All 1103 331.10 ± 42.51 [328.59e333.61] 27.07 ± 7.54 [26.62e27.51] 4.65 ± 1.08 [4.59e4.71]
18e29 97 350.71 ± 55.01 [339.63e361.8] 30.77 ± 6.43 [29.47e32.07] 5.04 ± 0.85 [4.87e5.21]
30e39 71 336.72 ± 44.31 [326.23e347.21] 30.09 ± 5.91 [28.69e31.48] 5.12 ± 0.83 [4.92e5.31]
40e49 144 325.29 ± 40.21 [318.67e331.92] 27.88 ± 7.13 [26.71e29.06] 4.88 ± 1 [4.71e5.04]
50e59 236 325.79 ± 37.97 [320.92e330.66] 27.26 ± 7.16 [26.35e28.18] 4.75 ± 1.05 [4.62e4.89]
60e69 265 334.83 ± 38.46 [330.18e339.49] 28.01 ± 8.06 [27.04e28.99] 4.76 ± 1.18 [4.62e4.91]
70 290 326.95 ± 43.36 [321.94e331.96] 23.64 ± 6.99 [22.84e24.45] 4.1 ± 0.97 [3.99e4.21]
40e44.9 All 1420 315.73 ± 38.76 [313.71e317.75] 25.26 ± 6.83 [24.91e25.62] 4.56 ± 1.08 [4.51e4.62]
18e29 108 330.36 ± 50.02 [320.82e339.91] 29.02 ± 5.64 [27.95e30.1] 5.04 ± 0.78 [4.89e5.19]
30e39 96 320.41 ± 33.37 [313.65e327.17] 27.95 ± 5.64 [26.81e29.1] 5.02 ± 1.07 [4.8e5.23]
40e49 221 308.32 ± 36.3 [303.51e313.14] 26.56 ± 6.93 [25.64e27.48] 4.91 ± 1.11 [4.77e5.06]
50e59 320 312.71 ± 34.62 [308.9e316.51] 26.34 ± 6.36 [25.64e27.03] 4.8 ± 0.99 [4.69e4.91]
60e69 369 318.54 ± 39.19 [314.52e322.55] 24.55 ± 6.57 [23.87e25.22] 4.39 ± 0.97 [4.29e4.49]
70 306 314.21 ± 39.55 [309.76e318.66] 21.9 ± 6.73 [21.15e22.66] 3.96 ± 1.04 [3.84e4.07]
45e49.9 All 862 299.99 ± 43.75 [297.06e302.91] 22.89 ± 6.79 [22.44e23.35] 4.36 ± 1.13 [4.28e4.43]
18e29 57 318.26 ± 60.5 [302.2e334.31] 27.5 ± 6.87 [25.67e29.32] 4.94 ± 0.86 [4.71e5.16]
30e39 72 312.66 ± 57.5 [299.15e326.18] 24.14 ± 7.57 [22.36e25.92] 4.48 ± 1.38 [4.15e4.8]
40e49 144 294.63 ± 46.16 [287.02e302.23] 23.8 ± 6.61 [22.71e24.89] 4.63 ± 1.18 [4.44e4.83]
50e59 198 295.27 ± 38.79 [289.84e300.71] 23.92 ± 6.03 [23.07e24.76] 4.61 ± 0.97 [4.48e4.75]
60e69 226 300.73 ± 38.57 [295.67e305.79] 21.9 ± 6.4 [21.06e22.74] 4.16 ± 1.06 [4.02e4.3]
70 165 297.45 ± 37.62 [291.67e303.24] 20.09 ± 6.59 [19.08e21.1] 3.84 ± 1.08 [3.67e4.01]
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Table 1 (continued )
Panel B
Women
BMI (kg/m2) class Age (yr) class N Rz/H (U/m) Xc/H (U/m) PhA ()
Mean ± SD 95% CI Mean ± SD 95% CI Mean ± SD 95% CI
≥50 All 761 268.84 ± 40.23 [265.98e271.71] 18.84 ± 6.10 [18.40e19.27] 4.36 ± 1.13 [4.28e4.44]
18e29 58 276.41 ± 39.82 [265.95e286.88] 20.62 ± 4.7 [19.38e21.85] 4.26 ± 0.77 [4.06e4.47]
30e39 81 277.56 ± 41.41 [268.4e286.72] 19.29 ± 6.33 [17.89e20.69] 3.94 ± 1.05 [3.71e4.18]
40e49 140 266.01 ± 38.52 [259.57e272.45] 19.71 ± 6.4 [18.64e20.78] 4.25 ± 1.35 [4.03e4.48]
50e59 197 263.78 ± 40.55 [258.08e269.48] 18.83 ± 6.4 [17.93e19.73] 4.05 ± 1.13 [3.89e4.21]
60e69 205 267.67 ± 39.02 [262.3e273.05] 18.01 ± 5.99 [17.18e18.83] 3.82 ± 1.05 [3.68e3.96]
70 80 274.97 ± 42.79 [265.45e284.49] 17.71 ± 5.34 [16.52e18.9] 3.69 ± 0.92 [3.48e3.89]
Table 2
Percentiles of Skeletal muscle index (Kg/m2) in men and women with mild to severe obesity.
Sex Age 10th 25th 50th 75th 90th
Men All 9.48 10.21 11.05 12.07 13.07
65 yr 9.82 10.48 11.35 12.42 13.41
65 yr 9.13 9.79 10.62 11.48 12.45
Female All 7.26 7.90 8.67 9.55 10.53
65 yr 7.53 8.08 8.87 9.72 10.71
65 yr 6.85 7.49 8.27 9.12 9.94
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significant for BMI values higher than 50 kg/m2 in men and women
patients both, demonstrating the poor nutritional status and the low
cellular integrity in case of extremely increased BMI (Fig. 2). Thus, the
BIA vector ellipses for men and women patients with obesity differ
from the reference population (Data not shown Fig. 3).
Hence the body compartments calculated as percentage of body
weight (FFM%) and as indexes (fat-free mass index FFMI, Kg/m2;Fig. 2. Phase angle decreasewith BMI (Kg/m2) increase in the studied cohort. Comparisons we
reference. Least Square means and their 95% confidence intervals and p-values are represen
3977skeletal muscle index, SMI, Kg/m2) in each considered BMI classes
were obtained and showed in Fig. 4. Globally, in each BMI class a
similar trend was present with an age-related decrease in FFM%
and an increase FM% (not shown) starting from the fifth decade of
life. By sex analysis, men obesity affected showed, for the same BMI
class, higher FFMI values thanwomen (p < 0.0001; Fig. 4). The FFMI
presented an increasing trend starting from 18years and peaking
around 50e59 years, then having a progressive decline (p < 0.0001)re made by sex (back box are men and gray box women) versus BMI class 30-34.9 kg/m2 as
ted (p-values with back represent men comparisons and with women comparisons).
Fig. 3. Comparison of confidence intervals for BIA vector distributions in normal weight subjects (continuous lines, derived from Piccoli et al. [24]) and obesity patients (dotted
liens). Confidence intervals are plotted on the RXc graph to represent the 50%, 75% and 95% centiles for the population studied.
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factor of the observed decline in FFM, in both sex (p < 0.0001).
Considering the large range of BMI and the large sample size
studied, we calculated the percentiles for SMI (kg/m2) by age and
gender for all obese patients (Fig. 5). The cut-off values for SMI,
used to define SM amount (kg) and to check whether there was a
decreased in muscle mass, a necessary parameter for the diagnosis
of sarcopenia [19] were used. Based on these cut-offs only 4% of
morbidly obese patients presented value that fell below these
limits, suggestive for a decreased muscle mass.
The observed percentile value for SMI (kg/m2) in men and
women patients were then subdivided by age less than 65 years,
representing possibly the effect of obesity alone, and over 65 years,
when a possible combined effect of both obesity and ageing occurs
(see Table 2). In the whole studied cohort values of SMI ¼ 11.05 kg/
m2 for men and of SMI ¼ 8.67 kg/m2 for women with body weight
in obesity range defined the 50th percentile of body skeletal muscle
mass.4. Discussion
The present BIA-based body composition analysis in a wide
cohort of patients suffering from mild to severe obesity when
analyzed by sex, age and BMI class revealed a significantly decreased
values for measured Rz and Xc with a consequent significant
decrease of PhA in a BMI-dependent manner. By mean group vector
analysis, the tolerance ellipses for patients with obesity had a dra-
matic difference from tolerance ellipses calculated in normal weight
population and actually used as reference in vectorial analysis.
Furthermore, the range for FFMI, FMI and SMI and the relative values
as percentage of body weight when analyzed in relation to age and
BMI showed a completely different trend in front of reference values
of normal-weight subjects. Because we excluded patients with
obesity and fluid overload, we conclude that the new ranges of body
composition parameters represent more realistic body composition
for diagnostic use in patients with obesity. Using impedance analysis
two elements appear relevant: PhA and vector position on the RXc
graph. Since PhA reflects the ratio between intra and extracellular
water, in obesity it may be affected by nutritional and hydration
status. In healthy subjects, PhA ranges between 6 and 7 [22] and in
athletes it may reach 8.5 [23] and low PhA values (such as less than
5) may indicate cellular integrity loss. Previous studies reported that
PhA might change in relation to sex, age and BMI. Women present
smaller PhA thanmen probably for less muscle mass [22] with lower3978PhAvalues seen in older people, probably for a reduction in Xc due to
a loss of muscle mass and an increase in Rz related to an increase FM
and reduction of body water [25]. The relationship with BMI is still
not well defined and it appears affected directly by body mass in-
crease in severely obese subjects (BMI>40 kg/m2), an inversely by
body fluid overload (ECW) [22]. Furthermore, different risk factors
such as hyperglycemia, inflammatory cytokine increase, high leptin
levels and insulin resistance were significantly higher in obese
womenwith lower PhA [26] suggesting that change in cell health for
different diseases appear relevant and we need reference values of
PhA for different clinical condition. We cannot test, in our popula-
tion, the presence of multimorbidity associated disease but, for
clinical use, appear interesting the possibility to monitoring the
progression of nutritional status or cardiovascular risk factors with
PhA. The length of BIVA vector indicates hydration status of soft
tissue [27]. Within the reference values, gender-specific, 75% toler-
ance ellipse indicate normal hydration; short vectors below this limit
indicate overhydration and long vectors above the 75% tolerance
ellipse indicate underhydration [15]. Significant vector displacement
is seen in different disease severity such as obesity [28] previously
reported that in severe obesity the vectorswere shorter than those in
the other groups and more frequently distributed on the left side of
the graph. This indicate an increase in TBW with a proportional in-
crease in ECW, due to increased soft tissue mass also with normal
tissue hydration. However, it is difficult to evaluate the body com-
partments with conventional BIA prediction equations but it is re-
ported that in most individuals with obesity, the increase in FM is
associated with a parallel increase in FFM [29]. Thus, our data
confirm that in adults with obesity, BIA analysis show a great
number of normal-hydrated patients but with reduced values of PhA
in relation to high BMI. The result is a shift of the mean vector,
including the 95% tolerance ellipse,with new reference values for the
consecutive BIA predictor equations of FFM, FM and SM.
We evaluated the reference range FFMI, FMI and SMI using
the measured values of Rz and Xc obtained by BIA and the derived
equations. Previous research [30e32] showed the importance of
normalizing FFM data by height because FFMI is more represen-
tative than FFM alone of nutrition status and considering that a
decreased height was associated with advancing age [22,33]. We
investigated the trend of each parameter in relation to age and BMI.
We found that FFMI differs for males and for females as previously
described [34e36]; furthermore, significant increases in FFMI
occurred between the ages of 15 and 23 years as expected due to
adolescent growth and remained relatively stable between the
Fig. 4. Fat free Mass as body weight percentage (%, panel A), as index (Kg of FFM/H, panel B) and SM index (SMI, Kg/m2) for each BMI class in age decades and subdivided by sex
(men, M and women, W).
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a decline was registered until 80 years. In a previous study, that
evaluated lean body mass index (LBMI) with DXA analysis in a large
group of Italian population (large range of BMI and age) a signifi-
cant increase was reported in both genders, and a significant and
progressive decline of FFMI associated with aging was shown
[34,37,38].
The FMI values were higher in females at all ages and increase
progressively with age (25e35yrs), remain stable until 65yrs when
decline [39]. When BMI increase, we registered an increase in FMI3979with higher values for women that was generally observed
[31,34,40]. This gender difference, that is not completely explained,
appears relevant as cardiovascular risk factor for female. As re-
ported in several studies, BIA analysis is used to muscle mass
assessment and sarcopenia diagnosis, but it is recommended the
use of normative data of the study population, generated from
appropriated equation/algorithm to be sure of reliable results [41].
Obesity might interfere in skeletal muscle mass assessment and
few data are available on the effect of obesity “per se” in skeletal
mass decline. Previous studies reported for the Italian population
Fig. 5. Percentile distribution of SMI (Kg/m2) in relation to age (years) in men (M) and women (W) affected by mild to morbid obesity.
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tively) for sarcopenia condition diagnosis in normal weight sub-
jects associated with disability and mortality [42e44]. Our results
demonstrated that the wide majority of patients with mild or se-
vere degree of obesity have increased values of SMI in relation to
BMI when compared to normal weight reference population. The
trend toward a SMI decreased amount was observed principally in
obese men after the fifth decade of life. We suggest new “normality
ranges” for SMI in obese patients considering the percentile dis-
tribution observed in men and women. Our data however need to
be validated in future studies and necessarily coupled with func-
tional tests (such as handgrip, time up and go, 6 min walking test
etc.) to better define the clinical relevance of these values and to
establish the possibility of use them as new cut-off values for a
proper sarcopenia diagnosis in patients with obesity.
Our study presents some possible limitations. The BIA is
considered not satisfactory in patients with severe obesity and
hyperhydration state. To avoid this bias, patients with known fluids
imbalance were excluded considering as hyperhydration a total
body water 80% (9.4% in the studied cohort). Then body compo-
sition assessment in these particular and category of patients re-
mains to be determined and studied. Furthermore, our previous
validation of phase sensitive tetrapolar SF-BIA against DXA in a
group of obese showed no significant differences (data not show),
although other BIA analyzers produce estimation of FFM values
slightly higher than DXA values [45e47]. This probably indicates
the need for new predictive equations adapted to men and women
affected by mild to morbid obesity. Additionally, a possible bias due
to data collection in two independent centers, despite performed
by highly trained personnel, cannot be excluded.
At present, no studies are available and no specific equations
have been validated in a population with BMI >35 kg/m2. In this
work, equations not validated for the obese population were used
for the calculation of fat free mass and skeletal muscle mass. Our
purpose was not to create an equation suitable for this population,
but to evaluate the goodness of those already available. The present
study, albeit descriptive, thanks to the large sample analyzed, could
be in the future suitable to improve and create new equations
adapted for patients with obesity.
5. Conclusions
In conclusion, with the present study we described BIA analysis
in a wide cohort of patients with obesity defining a picture of the3980FFMI and SMI values in Italian population in relation to age and BMI
classes. In particular, we demonstrated that PhA presented a
decrease vs a normal representation that we need to consider for a
correct evaluation of body composition in patients with obesity
and suggesting poor nutritional status. An accurate assessment of
nutritional status has three components (body composition, energy
balance and functionality). Therefore, it is essential to set up an
adequate treatment that must necessarily be of multidimensional
type. The BIA assessment of body composition of normal hydrated
subjects with obesity could represent a valid support to better
characterize the nutritional status of patients with obesity and to
plan a correct rehabilitation program aimed at reducing FM and
maintaining/increasing FFM.
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